Switching the Inhibitor-Enzyme Recognition Profile via Chimeric Carbonic Anhydrase XII

A key part of the optimization of small molecules in pharmaceutical inhibitor development is to vary the molecular design to enhance complementarity of chemical features of the compound with the positioning of amino acids in the active site of a target enzyme. Typically this involves iterations of synthesis, to modify the compound, and biophysical assay, to assess the outcomes. Selective targeting of the anti-cancer carbonic anhydrase isoform XII (CA XII), this process is challenging because the overall fold is very similar across the twelve CA isoforms. To enhance drug development for CA XII we used a reverse engineering approach where mutation of the key six amino acids in the active site of human CA XII into the CA II isoform was performed to provide a protein chimera (chCA XII) which is amenable to structure-based compound optimization. Through determination of structural detail and affinity measurement of the interaction with over 60 compounds we observed that the compounds that bound CA XII more strongly than CA II, switched their preference and bound more strongly to the engineered chimera, chCA XII, based on CA II, but containing the 6 key amino acids from CA XII, behaved as CA XII in its compound recognition profile. The structures of the compounds in the chimeric active site also resembled those determined for complexes with CA XII, hence validating this protein engineering approach in the development of new inhibitors.     

多壁碳纳米管固相萃取净化-高效液相色谱法测定猪肉和鸡肉中的磺胺多残留

建立了多壁碳纳米管为吸附剂的固相萃取净化-高效液相色谱-紫外检测测定猪肉和鸡肉中多种磺胺类药物多残留的方法。样品采用乙腈提取,多壁碳纳米管固相萃取净化,NaH₂PO₄缓冲溶液（pH 5.5~6.0）溶解上样,5%（v/v）丙酮-正己烷淋洗,丙酮-二氯甲烷（1：1,v/v）洗脱。色谱分离以50 mmol/L NaH₂PO₄-乙腈（7：3,v/v）为流动相,方法的线性范围为0.01~1.00 mg/L,线性相关系数大于0.998,检出限（LOD）为0.003 mg/L,定量限（LOQ）为0.01 mg/L。在0.02~0.2 mg/kg添加范围内,9种磺胺类药物的回收率高于70%,RSD低于8%,表明多壁碳纳米管对磺胺类药物具有较强的吸附富集能力。该方法简便、准确可用于动物组织及产品中磺胺药物残留的检测。     

超高效液相色谱-串联质谱法同时测定鸡肉中的二氯二甲吡啶酚、磺胺类和喹诺酮类药物残留

采用超高效液相色谱-串联质谱（UPLC-MS/MS）在正离子模式下通过多反应监测（MRM）方式同时测定了鸡肉组织中二氯二甲吡啶酚、磺胺嘧啶、磺胺二甲基嘧啶、磺胺对甲氧嘧啶、磺胺甲氧哒嗪、诺氟沙星、氧氟沙星、环丙沙星、恩诺沙星等9种药物残留。试样经乙腈均质提取,冷冻离心脱脂,旋转蒸发浓缩,用流动相复溶后经乙腈饱和的正己烷除油,随后进行UPLC-MS/MS定性定量分析。该方法测定9种药物的检出限为0.1 μg/kg,定量限为0.5 μg/kg。在添加水平分别为0.5、1.0和2.0 μg/kg时,9种药物的加标回收率为81.5%~97.6%,相对标准偏差（RSD）为2.1%~8.9%。该方法简便、准确,可作为鸡肉中9种药物残留检测的确证方法。     

Photolysis of the Sulfonamide Bond of Metal Complexes of N‐Dansyl‐1,4,7,10‐Tetraazacyclododecane in Aqueous Solution: A Mechanistic Study and Application to the Photorepair of cis,syn‐Cyclobutane Thymine Photodimer

Conditional cleavage : Photochemical S? N bond cleavage of the Zn²⁺ complex of N‐dansylcyclen (ZnL²) in aqueous solution was investigated. Moreover, photolysis of ZnL² (see scheme) facilitated photoreversion of cis,syn‐thymine photodimer (T[c,s]T).

     

高效液相色谱-柱后衍生法检测养殖水体及沉积物中11种磺胺药物残留

建立了养殖水体及沉积物中11种磺胺化合物的高效液相色谱-柱后衍生分析方法。养殖水体过滤后采用HLB固相萃取柱进行净化、富集;沉积物采用甲醇/EDTA-Mcllvaine缓冲液(1:1, v/v)提取,HLB固相萃取柱净化富集。经高效液相色谱分离,用荧光胺衍生试剂进行柱后衍生,荧光检测器检测。对柱后衍生系统参数进行了优化,确定了荧光胺溶液的浓度、流速和反应温度分别为0.2 g/L、0.15 mL/min和50 ℃,磺胺化合物在0.01~1.0 mg/L范围内线性显著,其相关系数r²值大于0.99995。11种磺胺类药物在养殖水体和沉积物中的加标回收率分别为79.3%~100.7%和74.6%~95.3%,相对标准偏差为2.2%~11.0%和2.6%~10.3%,检出限(LOD, S/N=3)为0.9~5.5 ng/L和0.3~1.3 μg/kg,定量限(LOQ, S/N=10)为3.0~18.1 ng/L和1.0~4.4 μg/kg。该法可应用于养殖环境中磺胺类药物的定性定量检测,具有较好的实用性。     

超高效液相色谱-串联质谱法同时测定化妆品中的22种磺胺类药物

建立了同时测定化妆品中22种磺胺类药物(磺胺胍、磺胺、磺胺嘧啶、磺胺二甲异嘧啶、磺胺醋酰、磺胺噻唑、磺胺吡啶、磺胺甲基嘧啶、磺胺对甲氧嘧啶、磺胺二甲噁唑、磺胺二甲嘧啶、磺胺甲噻二唑、磺胺甲氧哒嗪、琥珀酰磺胺噻唑、磺胺氯哒嗪、磺胺甲基异噁唑、磺胺间甲氧嘧啶、磺胺邻二甲氧嘧啶、磺胺二甲异噁唑、磺胺间二甲氧嘧啶、磺胺喹噁啉、磺胺硝苯)的超高效液相色谱-串联质谱分析方法。膏霜、水剂、散粉、香波、唇膏等不同类型的化妆品样品经超声提取后,以Waters ACQUITY UPLC BEH C18色谱柱(50 mm×2.1 mm,1.7μm)分离后进行UPLC/MS/MS多反应监测模式下的定性及定量分析。22种磺胺类药物的方法检出限为3.5~14.1μg/kg;在低、中、高的3个添加水平范围内的平均回收率为80.3%~103.6%;日内精密度均小于12%,日间精密度均小于15%。     

Pyrazolo[4,3-e]tetrazolo[1,5-b][1,2,4]triazine Sulfonamides as Novel Potential Anticancer Agents: Cytotoxic and Genotoxic Activities In Vitro

In this paper, we present for the first time the evaluation of cytotoxicity and genotoxicity of de novo synthesized pyrazolo[4,3-e]tetrazolo[1,5-b][1,2,4]triazine sulfonamides MM129, MM130, and MM131 in human tumor cell lines: HeLa, HCT 116, PC-3, and BxPC-3. Cytotoxic and genotoxic properties of the tested compounds were estimated using the MTT assay, comet assay (alkaline and neutral version), and γ-H2AX immuno-staining. Examined sulfonamides exhibited strong anticancer properties towards tested cells in a very low concentration range (IC₅₀ = 0.17–1.15 μM) after 72 h exposure time. The results of the alkaline and neutral version of the comet assay following 24 h incubation of the cells with tested compounds demonstrated the capability of heterocycles to induce significant DNA damage in exposed cells. HCT 116 cells were the most sensitive to the genotoxic activity of novel tricyclic pyrazolo[4,3-e]tetrazolo[1,5-b][1,2,4]triazine sulfonamides in the neutral version of the comet assay. Immunocytochemical detection of γ-H2AX showed an increase in DNA DSBs level in the HCT 116 cell line, after 24 h incubation with all tested compounds, confirming the results obtained in the neutral comet assay. Among all investigated compounds, MM131 showed the strongest cytotoxic and genotoxic activity toward all tested cell types. In conclusion, our results suggest that MM129, MM130, and MM131 exhibit high cytotoxic and genotoxic potential in vitro, especially towards the colorectal cancer cell line HCT 116. However, further investigations and analyses are required for their future implementation in the field of medicine.     

Calculation of solvation and binding free energy differences between VX-478 and its analogs by free energy perturbation and AMSOL methods

Summary VX-478 belongs to a novel class of HIV-1 protease inhibitors that are based on N,N-disubstituted benzene sulfonamides. Force field parameters for the N,N-dialkyl benzene sulfonamide moiety have been assembled from the literature and from our own ab initio calculations. These parameters were employed to calculate solvation and binding free energy differences between VX-478 and two analogs. The free energy perturbation method has been used to determine these differences using two approaches. In the first approach, intergroup interaction terms only were included in the calculation of free energies (as in most reports of free energy calculations using AMBER). In the second approach, both the inter- and intragroup interaction terms were included. The results obtained with the two approaches are in excellent agreement with each other and are also in close agreement with the experimental results. The solvation free energies of N,N-dimethyl benzene sulfonamide derivatives (truncated models of the inhibitors), calculated using continuum solvation (AMSOL) methods, are found to be in qualitative agreement with the experimental and free energy perturbation results. The binding and solvation free energy results are discussed in the context of structure-based drug design to show how physicochemical properties (for example aqueous solubilities and bioavailabilities) of these HIV-1 protease inhibitors were improved, while maintaining their inhibitory potency.     

Reactions of sulfonamides with 4,5-dihydroxyimidazolidin-2-ones

The interaction of sulfonamides with 4,5-dihydroxyimidazolidin-2-ones was studied for the first time. The earlier unknown 4,4′-sulfonyldiiminobis(1,3-dialkylimidazolidin-2-ones) and 4(5)-aryl(alkyl)-sulfonyliminoimidazolidin-2-ones were synthesized. A probable pathway of the reaction was proposed. 1,3-Diethyl-4,5-dihydroxyimidazolidin-2-one was isolated and described. Translated fromIzvestiya Akademii Nauk. Seriya Khimicheskaya, No. 8, pp. 1604–1607, August, 1998.     

Countercurrent Chromatography for the Measurement of the Hydrophobicity of Sulfonamide Amphoteric Compounds

Octanol-water partition coefficients (P _o/w ) of 17 sulfonamides (SAs) were determined by countercurrent chromatography (CCC). The measured P _o/w values were in the 0.002–46 range (–2.65 < log P _o/w < 1.7). The lipophility of these compounds depends on the pH showing a maximum for intermediate values. The apparent P _o/w coefficients of SAs were obtained at 5 pH values: 2, 3, 5, 7 and 11, using 0.01 M ammonium phosphate octanol saturated buffers. A theoretical model linking these values with pH for amphoteric compounds was checked and verified. Often the P _o/w coefficients of the molecular forms obtained with the CCC method differ significantly from literature values obtained using softwares and/or from experimental values calculated with extrapolation. The CCC method allows also the determination of the P _o/w coefficients of the ionic forms of the SAs, cationic forms at low pH values and anionic forms at elevated pHs. The acidity constants were also estimated using the theoretical model. Relationships between SA retention factors obtained by RPLC and hydrophobicity were also discussed.